Sequential patterns of chemokine- and chemokine receptor-synthesis following vessel wall injury in porcine coronary arteries.
Inflammation plays a central role in vascular repair, and spreads into perivascular tissue (PVT) following angioplasty. Chemokines (CK) and chemokine receptors (CKR) are key determinants of inflammatory chemotaxis. We sought to assess the arterial and perivascular expression of the CK CCL2 and CXCL2, and the CKR CCR2, CCR5, and CXCR4 in balloon-injured porcine coronary arteries. Vascular cells that express specific CK and CKR mRNA during post-angioplasty time course were detected by in situ hybridization (ISH), and expression was quantified by real time RT-PCR in PVT. CCL2 was maximal in PVT from 2 to 24h post injury, coincident with local macrophage-activation. Expression was upregulated in media and adventitia from 24h to 3 days, and in neointima at 7 days. CXCL2 was detected in media at 2 and 4h, and also in some neointimal cells. CCR2 and CCR5 were maximal in PVT at 24h and 3 days, respectively. Expression shifted to media and adventitia at 2 and 3 days, and to neointima and adventitia at 7 days, and was low at 14 days. CXCR4 was low in PVT, but was upregulated in media and adventitia at 2 and 3 days, as well as in neointima and adventitia at 7 days. In conclusion, PVT is the primary source of inflammatory CK and CKR early post-angioplasty. Specific sequential patterns of CK- and CKR-synthesis are identified that may regulate phase-specific chemotaxis by spatio-temporally differential expression during coronary response to injury.
Jabs
Alexander
A
Winship Cancer Institute Department of Hematology/Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Okamoto
Ei-ichi
E
Vinten-Johansen
Jakob
J
Bauriedel
Gerhard
G
Wilcox
Josiah N
JN
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000818:Animals; D018932:Chemokine CCL2 / Q000378:metabolism*; D019743:Chemokines, CXC / Q000378:metabolism*; D002633:Chemotaxis / Q000276:immunology; D003238:Connective Tissue / Q000276:immunology; D023903:Coronary Restenosis / Q000276:immunology*; D003331:Coronary Vessels / Q000276:immunology / Q000293:injuries* / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D020869:Gene Expression Profiling; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007249:Inflammation / Q000276:immunology; D019707:Receptors, Chemokine / Q000378:metabolism*; D034421:Sus scrofa; D017539:Tunica Intima / Q000276:immunology / Q000378:metabolism; D017540:Tunica Media / Q000276:immunology / Q000378:metabolism; D014945:Wound Healing / Q000276:immunology*
D018932:Chemokine CCL2; D019743:Chemokines, CXC; D019707:Receptors, Chemokine